États-Unis · Plateformes & données · MarketBeat

Emergent Biosolutions Q3 Earnings Call Highlights

Publié par MarketBeat · États-Unis il y a 2 h

Emergent Biosolutions (NYSE:EBS) reported third-quarter revenue within its guidance range and updated its full-year outlook, while continuing a multiyear transformation focused on…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Emergent Biosolutions Q3 Earnings Call Highlights

À lire aussi

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

JAKKS Pacific: 3 Key Takeaways for Long-Term Investors

Apple’s iPhone business is booming. Here’s why the stock is falling anyway.

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

Stock market after midterm elections: What S&P 500 history shows

UBS MSCI World Selection UCITS ETF hEUR acc CSY7 ETF Analysis

Emergent Biosolutions Q3 Earnings Call Highlights

Partager

À lire aussi

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

JAKKS Pacific: 3 Key Takeaways for Long-Term Investors

Apple’s iPhone business is booming. Here’s why the stock is falling anyway.

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

Stock market after midterm elections: What S&P 500 history shows

UBS MSCI World Selection UCITS ETF hEUR acc CSY7 ETF Analysis